Online citations, reference lists, and bibliographies.
← Back to Search

Iron Transport Tocopheryl Polyethylene Glycol Succinate In Animal Health And Diseases

Ajay Srivastava, R. Lall, Jamil Talukder, D. Dubourdieu, R. Gupta
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Gut health is the starting place for maintaining the overall health of an animal. Strategies to maintain gut health are, thus, an important part in achieving the goal of improving animal health. A new strategy to do this involves two molecules: the iron transport protein ovotransferrin (IT) and α-tocopheryl polyethylene glycol succinate (TPGS), which result in the novel formulation of ITPGS. These molecules help reduce gut pathogens, while enhancing the absorption and bioavailability of therapeutic drugs, phytomedicines, and nanomedicines. This, in turn, helps to maintain normal health in animals. Maintaining the gastrointestinal tract (GIT) in its normal condition is key for successful absorption and efficacy of any nutrient. A compromised GIT, due to an imbalance (dysbiosis) in the GIT microbiome, can lead to an impaired GI barrier system with impaired absorption and overall health of the animal. The molecules in ITPGS may address the issue of poor absorption by keeping the GI system healthy by maintaining the normal microbiome and improving the absorption of nutrients through multiple mechanisms involving antioxidative, anti-inflammatory, immunomodulatory, and antimicrobial activities. The ITPGS technology can allow the dose of active pharmaceutical or herbal medicine to be significantly reduced in order to attain equal or better efficacy. With complimentary actions between IT and TPGS, ITPGS presents a novel approach to increase the bioavailability of drugs, phytoconstituents, nutrients, and nanomedicines by enhanced transport to the tissues at the site of action, while reducing gut pathogen load. The ITPGS approach appears to be a novel strategy for maintaining the health of animals by manipulation of microbiota.
This paper references
10.1016/j.freeradbiomed.2011.02.032
Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy.
Lan-feng Dong (2011)
10.1021/jf405635q
Conjugation of ovotransferrin with catechin shows improved antioxidant activity.
J. You (2014)
Using tocophersolan for drug
Y. Robin (2019)
10.1016/j.jaci.2018.09.025
Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review
P. Zimmermann (2019)
10.1016/j.phrs.2018.01.013
Gut microbiota, hypertension and chronic kidney disease: Recent advances.
Antonio Sircana (2019)
10.1016/S0891-5849(99)00121-5
Vitamin E regulates mitochondrial hydrogen peroxide generation.
C. Chow (1999)
Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats.
I. Ikeda (1996)
10.1186/s12877-017-0621-2
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon (2017)
The application of vitamin E TPGS in drug
Y. Guo (2013)
10.2174/0929867043365332
Non-antioxidant activities of vitamin E.
J. Zingg (2004)
10.1016/j.fct.2016.11.001
An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
A. C. Brown (2017)
10.1292/JVMS.57.825
Enhancing effects of chicken egg white derivatives on the phagocytic response in the dog.
Y. Hirota (1995)
10.1007/s00394-017-1445-8
Gut microbiota functions: metabolism of nutrients and other food components
I. Rowland (2017)
10.1016/J.SURG.2007.01.021
The gut is a motor of organ system dysfunction.
C. L. Leaphart (2007)
10.1016/J.FREERADBIOMED.2005.06.013
Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice.
S. Khanna (2005)
10.1006/JMCC.1993.1119
Effect of alpha-tocopherol on high energy phosphate metabolite levels in rat heart by 31P-NMR using a Langendorff perfusion technique.
M. Kotegawa (1993)
10.1211/0022357011775208
Pharmacokinetics and bioavailability of α‐, γ‐ and δ‐tocotrienols under different food status
S. P. Yap (2001)
10.1016/j.bbrc.2013.04.013
The protective effects of lactoferrin against murine norovirus infection through inhibition of both viral attachment and replication.
H. Ishikawa (2013)
10.1126/science.1223813
Host-Gut Microbiota Metabolic Interactions
J. Nicholson (2012)
10.1007/s002800050258
Inhibition of intestinal P-glycoprotein and effects on etoposide absorption
Bee-Lien Leu (2009)
D-alpha-tocopheryl glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood
E. A. Argao (1992)
10.1139/Y07-004
Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice.
M. J. Talukder (2007)
10.1146/ANNUREV.BI.58.070189.001033
The biochemistry of P-glycoprotein-mediated multidrug resistance.
J. A. Endicott (1989)
10.1016/j.cell.2005.05.007
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
S. Mazmanian (2005)
Infection, the gut and the development of the multiple organ dysfunction syndrome.
G. Nieuwenhuijzen (1996)
10.1016/j.cell.2013.12.016
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
F. Vadder (2014)
10.3389/fvets.2018.00249
Herbal Bioenhancers in Veterinary Phytomedicine
B. Yurdakok-Dikmen (2018)
10.1016/B978-0-12-802147-7.00009-7
Nutraceuticals in Gastrointestinal Disorders
A. Banerjee (2016)
10.1016/J.IJBIOMAC.2007.08.005
Ovotransferrin possesses SOD-like superoxide anion scavenging activity that is promoted by copper and manganese binding.
H. Ibrahim (2007)
10.1089/ars.2013.5594
Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis.
J. Truksa (2015)
10.1016/j.rgmx.2013.04.004
[Gut microbiota in health and disease].
M. E. Icaza-Chávez (2013)
10.3410/B2-27
Advances in understanding the interaction between the gut microbiota and adaptive mucosal immune responses
A. Neish (2010)
10.3109/03639041003695139
Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer
Y. Gao (2010)
10.1051/RND:19940309
Tissue alpha-tocopherol concentrations following supplementation with various forms of vitamin E in sheep.
N. Hidiroglou (1994)
10.1016/j.tvjl.2015.03.018
Characterization and comparison of the bacterial microbiota in different gastrointestinal tract compartments in horses.
M. Costa (2015)
10.1097/RLI.0b013e3181a16762
Magnetic Resonance Imaging Detects Intestinal Barrier Dysfunction in a Rat Model of Acute Mesenteric Ischemia/Reperfusion Injury
J. Hsiao (2009)
10.1155/2013/848043
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
S. Gupta (2013)
10.3390/ph9040061
Lactoferrin from Milk: Nutraceutical and Pharmacological Properties
F. Giansanti (2016)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
10.3382/ps.2012-02150
Antioxidant effects of ovotransferrin and its hydrolysates.
J. Kim (2012)
10.1016/j.colsurfb.2015.11.050
Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
P. Ramalingam (2016)
10.1007/s00535-008-2293-3
Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells
T. Omatsu (2008)
10.1016/j.phrs.2018.02.028
Gut microbiota in kidney disease and hypertension
C. Antza (2018)
10.1021/mp900191s
Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.
E. Collnot (2010)
10.1016/J.FREERADBIOMED.2003.10.009
New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine
K. Hensley (2004)
10.3109/10715769109088952
Absorption, transport and metabolism of vitamin E.
C. Drevon (1991)
10.1208/s12249-011-9632-z
Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats
W. Chen (2011)
10.1021/mp400086n
TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance.
T. Zou (2013)
10.1016/j.freeradbiomed.2014.03.035
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy.
Q. Jiang (2014)
10.1039/c8fo02312c
Ovotransferrin ameliorates the dysbiosis of immunomodulatory function and intestinal microbiota induced by cyclophosphamide.
Gaoxiang Zhu (2019)
Indian Herbal Bioenhancers: A Review
R. Singh (2009)
10.1177/153537020623100807
Effects of Commensal Bacteria on Intestinal Morphology and Expression of Proinflammatory Cytokines in the Gnotobiotic Pig
T. W. Shirkey (2006)
10.1016/S0378-5173(02)00544-6
Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.
Y. V. R. Prasad (2003)
10.1016/J.FREERADBIOMED.2007.03.024
Vitamin E, antioxidant and nothing more.
M. Traber (2007)
10.1111/J.1439-0450.2004.00785.X
Prevalence and antimicrobial resistance of Salmonella spp. in non-diarrhoeic dogs in Trinidad.
N. Seepersadsingh (2004)
10.1016/B978-0-12-802147-7.00057-7
Synbiotics: Safety and Toxicity Considerations
J. K. Malik (2016)
10.3389/fphar.2018.01354
Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines
Wuwen Feng (2018)
10.1007/978-94-011-2364-8_6
Factors affecting the microecology of the gut
R. Freter (1992)
10.1007/s11095-005-9262-9
Advances in the Use of Tocols as Drug Delivery Vehicles
P. Constantinides (2005)
10.1517/13543776.2011.561784
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
N. Akhtar (2011)
Egg derived ovotransferrin and lactoferrin
J. Talukder (2019)
10.1016/j.phrs.2018.01.019
The role of gut microbiota in the pharmacokinetics of antihypertensive drugs
M. S. Choi (2018)
10.1080/07853890.2016.1197414
Herbal medications and other dietary supplements. A clinical review for physicians caring for older people
K. Pitkälä (2016)
10.3389/fphar.2019.00769
Synthesis of TPGS/Curcumin Nanoparticles by Thin-Film Hydration and Evaluation of Their Anti-Colon Cancer Efficacy In Vitro and In Vivo
Huimei Li (2019)
10.1016/j.smim.2017.09.006
Microbiome, inflammation and colorectal cancer.
J. Chen (2017)
10.1136/vr.154.4.101
Prevalence of enteropathic Escherichia coli in dogs with acute and chronic diarrhoea
A. A. Sancak (2004)
10.1097/MOG.0b013e3282f323f3
Nutrition and colonic health: the critical role of the microbiota
S. O'keefe (2008)
Genes in the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells
G. Paesold (2002)
10.1016/j.rvsc.2018.11.019
Mucosal immunity and gut microbiota in dogs with chronic enteropathy.
N. Eissa (2019)
10.1023/A:1018939006780
Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1
L. Yu (2004)
10.1186/gb-2013-14-1-r4
Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice
F. Hildebrand (2012)
10.1016/J.MOLIMM.2004.12.003
Bacterial modulation of mucosal innate immunity.
D. Kelly (2005)
10.7150/thno.22711
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Conglian Yang (2018)
10.1016/j.biomaterials.2012.03.046
Vitamin E TPGS as a molecular biomaterial for drug delivery.
Zhiping Zhang (2012)
10.1016/0005-2760(84)90253-4
Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins
J. Massey (1984)
10.1111/imm.13037
Impact of gut microbiota on gut‐distal autoimmunity: a focus on T cells
Maran L Sprouse (2019)
Biopotentiation using Herbs: Novel Technique for Poor Bioavailable Drugs
B. Jhanwar (2014)
Vitamin E and oxidative stress. Free Radic
C K Chow (1991)
10.1111/1574-6976.12086
Nutritional iron turned inside out: intestinal stress from a gut microbial perspective.
G. Kortman (2014)
10.1038/nmicrobiol.2016.177
Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks
Y. Vázquez-Baeza (2016)
10.1016/J.FOODCHEM.2010.04.083
Oxygen radical absorbance capacity of peptides from egg white protein ovotransferrin and their interaction with phytochemicals.
W. Huang (2010)
10.3402/mehd.v26.25877
Manipulating the gut microbiota to maintain health and treat disease
K. Scott (2015)
10.1016/0891-5849(93)90078-9
Molecular pharmacology of vitamin E: structural aspects of antioxidant activity.
S. Van Acker (1993)
10.1016/J.JSS.2007.04.039
Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling.
M. J. Redlak (2008)
10.1016/J.ANTIVIRAL.2006.09.002
Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides.
M. Ammendolia (2007)
10.1016/0378-8741(92)90067-2
An Ayurvedic formulation 'Trikatu' and its constituents.
R. Johri (1992)
Anti-inflammatory activities of lactoferrin
O. M. Connely (2001)
10.1016/j.tim.2011.05.006
Understanding the role of gut microbiome-host metabolic signal disruption in health and disease.
E. Holmes (2011)
10.3748/wjg.v20.i44.16489
Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs.
Julia B Honneffer (2014)
10.1038/4441022a
Microbial ecology: Human gut microbes associated with obesity
Ruth E. Ley (2006)
10.1016/j.micpath.2007.12.004
Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection.
A. N. Flynn (2008)
10.1124/pr.118.015768
Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions
G. Clarke (2019)
10.1186/s12906-019-2545-1
Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract
A. Pandit (2019)
Lymphatic transport ofα-, γ-, andδ-tocotrienol and α-tocopherol in rat
I. Ikeda (1996)
Role of free radicals in ischemic rat liver cell injury: Prevention of damage by α-tocopherol administration
S. Marubayashi (1986)
Using Tocophersolan for Drug Delivery
Y. Robin (2015)
Use of Herbal Bioenhancers to Increase the Bioavailability of Drugs
S. Drabu (2011)
10.1179/1351000213Y.0000000064
Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy
J. Kovářová (2014)
Drug discovery for the future
A S Reddy (2013)
10.1016/S0009-9236(96)80007-5
The effect of water‐soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers
T. Chang (1996)
10.1002/bdd.1790
Comparison of the intestinal absorption and bioavailability of γ‐tocotrienol and α‐tocopherol: in vitro, in situ and in vivo studies
B. Abuasal (2012)
10.1194/JLR.M500143-JLR200
Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500143-JLR200
Jinghui Qian (2005)
10.1016/J.EJPS.2005.04.003
Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
M. Varma (2005)
Treatment of Infectious Endometritis with a Novel Protein, VPI-O22, in Cows
Jamil Talukder (2018)
10.1016/S2221-1691(13)60060-X
Bioavailability enhancers of herbal origin: an overview.
K. Kesarwani (2013)
10.1016/j.cveq.2017.11.005
Understanding the Intestinal Microbiome in Health and Disease.
M. Costa (2018)
10.1186/s13073-016-0303-2
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
C. Boulangé (2016)
10.1136/gutjnl-2015-309990
The gut microbiota and host health: a new clinical frontier
J. Marchesi (2015)
10.1186/s13567-019-0663-x
Host intestinal biomarker identification in a gut leakage model in broilers
Fien De Meyer (2019)
10.1016/j.fitote.2014.05.005
Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.
Ajazuddin (2014)
10.1002/ijc.23689
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
C. Constantinou (2008)
10.1016/S0261-5614(98)80311-7
Effect of α-tocopherol pretreatment on high energy metabolites in rabbit skeletal muscle after ischemiareperfusion
A. Punz (1998)
10.1007/978-3-030-04624-8_19
Prebiotics and Probiotics in Feed and Animal Health
A. Anadón (2019)
10.1126/science.1223490
Interactions Between the Microbiota and the Immune System
L. Hooper (2012)
10.1211/002235702450
Therapeutic usefulness of Keishi‐bukuryo‐gan for diabetic nephropathy
Takako Nakagawa (2003)
10.1002/JPS.10008
Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole.
V. Wacher (2002)
10.1023/A:1015000503629
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
J. M. Dintaman (2004)
10.1080/10717544.2016.1176087
Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer
X. Guan (2016)
10.4291/wjgp.v3.i1.27
Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.
L. Yu (2012)
Comparison of the intestinal absorption and bioavailability of gamma-tocotrienol and alpha-tocopherol: In vitro, in situ and in vivo studies
B. S. Abuasal (2012)
10.3390/ijms16047493
Impacts of Gut Bacteria on Human Health and Diseases
Y. Zhang (2015)
10.3390/ph11040098
Gut Microbiota and Iron: The Crucial Actors in Health and Disease
B. Yilmaz (2018)
10.3945/an.116.013151
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.
Z. Mokhtari (2017)
10.1021/MP060121R
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
E. Collnot (2007)
10.1016/j.jconrel.2012.05.031
Development of a novel drug delivery system consisting of an antitumor agent tocopheryl succinate.
S. Hama (2012)
10.1016/B978-0-12-802147-7.00054-1
Prebiotics: Safety and Toxicity Considerations
A. Anadón (2016)
10.1136/vr.103826
Role of the gastrointestinal microbiota in small animal health and disease
Alana Redfern (2017)
10.1038/nri3430
Role of the gut microbiota in immunity and inflammatory disease
N. Kamada (2013)
Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy. Free Radic
L F Dong (2011)
10.1016/j.brainres.2018.03.015
Neurotransmitter modulation by the gut microbiota
Philip Strandwitz (2018)
10.1016/J.JCONREL.2004.10.030
Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
Wen-ting Ke (2005)
10.1586/ecp.12.74
Polypharmacology: drug discovery for the future
A. S. Reddy (2013)
Relevance of gut microbiota in cognition, behaviour and Alzheimer’s disease
V.D.R. De-Paula (2018)
Role of free radicals in ischemic rat liver cell injury: prevention of damage by alpha-tocopherol administration.
S. Marubayashi (1986)
10.1055/S-0031-1299951
Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.
B. Bittner (2002)
10.1046/j.1462-5822.2002.00233.x
Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella‐induced apoptosis in intestinal epithelial cells
G. Paesold (2002)
10.1155/2015/584862
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives
C. Neophytou (2015)
10.1186/s40168-017-0267-5
Optimizing methods and dodging pitfalls in microbiome research
Dorothy Kim (2017)
10.1111/J.1574-6968.1983.TB00504.X
Lactobacillus plantarum, an organism not requiring iron
F. Archibald (1983)
10.1093/AJCN/48.3.605
Uptake of intact TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro.
M. Traber (1988)
10.1203/00006450-199202000-00011
d-α-Tocopheryl Polyethylene Glycol-1000 Succinate Enhances the Absorption of Vitamin D in Chronic Cholestatic Liver Disease of Infancy and Childhood
Eric A Argao (1992)
10.1002/ana.24901
The gut microbiome in human neurological disease: A review
H. Tremlett (2017)
Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats.
S. P. Yap (2003)
10.1016/J.JCONREL.2005.05.014
Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol
Hee-Jeong Youk (2005)
10.1016/S0304-4165(00)00122-7
Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism.
H. Ibrahim (2000)
10.1139/cjpp-2013-0211
Lactoferrin ameliorates prostaglandin E2-mediated inhibition of Na+ -glucose cotransport in enterocytes.
Jamilur R. Talukder (2014)
Studies of the antimicrobial activity of ovotransferrin.
P. Valenti (1983)
10.1016/j.ijpharm.2012.08.038
Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
Yu Mi (2012)
10.1007/978-0-387-09550-9_2
The commensal microbiology of the gastrointestinal tract.
J. Manson (2008)
10.1093/nutrit/nuv039
Potential role of the intestinal microbiota in programming health and disease.
O. Goulet (2015)
10.3382/ps.2013-03649
Separation of ovotransferrin and ovomucoid from chicken egg white.
E. D. N. S. Abeyrathne (2014)
10.1016/j.ejps.2013.02.006
The applications of Vitamin E TPGS in drug delivery.
Y. Guo (2013)
10.1080/07315724.2001.10719173
Antiinflammatory Activities of Lactoferrin
O. Conneely (2001)
10.1016/j.phrs.2018.07.007
Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease
Vanessa de J.R. De‐Paula (2018)
10.1371/journal.pone.0127259
Characterization of Microbial Dysbiosis and Metabolomic Changes in Dogs with Acute Diarrhea
B. Guard (2015)
Strategies for enhancement of bioavailability of medicinal agents with natural products
G. Jain (2015)
10.1034/J.1600-0773.2002.T01-1-910403.X
The involvement of P-glycoprotein in berberine absorption.
G. Pan (2002)
10.1186/s12917-016-0736-2
Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
J. Xu (2016)
Prevalence and antimicrobial resistance of Salmonella Spp. in non-diarrheic dogs in Trinidad
N. Seepersadsingh (2004)
Delivery of orally supplemented α-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic
S Khanna (2005)
10.1021/jf101323y
Identification of novel antioxidative peptides derived from a thermolytic hydrolysate of ovotransferrin by LC-MS/MS.
S. Shen (2010)
10.1016/S0168-3659(02)00025-1
Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
L. Mu (2002)
10.1080/07315724.2007.10719647
The Physiological Relevance of the Intestinal Microbiota - Contributions to Human Health
K. Tappenden (2007)
Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.
Hee-Jeong Youk (2005)
10.1007/978-3-030-04624-8_31
Nutraceuticals in Gastrointestinal Conditions
Jamil Talukder (2019)
10.1371/journal.pone.0041594
Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn’s Disease
M. Craven (2012)
10.1016/j.cell.2004.07.002
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
S. Rakoff-Nahoum (2004)
10.1038/ejcn.2017.89
Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women
J. Most (2017)
10.1038/laban.1222
Microbiota and reproducibility of rodent models
C. Franklin (2017)
Characteristics of D-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems
S. Wu (1999)
10.1111/j.1471-4159.2006.04000.x
Characterization of the potent neuroprotective properties of the natural vitamin E α‐tocotrienol
S. Khanna (2006)
10.1093/JN/121.8.1208
Effect of dietary deficiency and supplementation with all-rac-alpha-tocopherol on hepatic content in rats.
A. Bjørneboe (1991)
10.1016/S0161-5890(03)00152-4
Lactoferrin--a multifunctional protein with antimicrobial properties.
S. Farnaud (2003)
Quercetin-loaded poly(lactic-co-glycolic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Drug Deliv
X Guan (2016)
10.1016/B978-0-12-802147-7.00021-8
Target Identification and Polypharmacology of Nutraceuticals
György Dormán (2016)
10.1128/IAI.72.7.3849-3854.2004
Intestinal P Glycoprotein Acts as a Natural Defense Mechanism against Listeria monocytogenes
B. L. Neudeck (2004)
10.1053/j.gastro.2008.10.080
Microbes in gastrointestinal health and disease.
A. Neish (2009)
10.1016/J.CARBON.2007.08.035
Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and Fullerenes.
Aihui Yan (2007)
10.1016/j.jep.2018.01.021
Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
H. Shen (2018)
Role of the gut microbiota in immunity and inflammatory disease
N. Kamadan (2013)
10.1038/s41598-017-03123-y
Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier
X. Meng (2017)
Bioavailability enhancing activities of natural compounds from medicinal plants.
Kang Myungjoo (2009)
10.3389/fphar.2018.01126
Antidepressant Effects of Rosemary Extracts Associate With Anti-inflammatory Effect and Rebalance of Gut Microbiota
Y. Guo (2018)
10.1126/science.288.5464.287
Infectious History
J. Lederberg (2000)
Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
C. K. Atal (1985)
10.1097/00075197-199909000-00008
The gut: the 'motor' of multiple organ dysfunction syndrome?
Nieuwenhuijzen Ga (1999)
10.1128/mBio.01418-18
Exposure to Arsenite in CD-1 Mice during Juvenile and Adult Stages: Effects on Intestinal Microbiota and Gut-Associated Immune Status
K. Gokulan (2018)
10.1111/j.2042-7158.2003.tb02433.x
Influence of route of administration on the absorption and disposition of α,‐ γ‐ and δ‐tocotrienols in rats
S. P. Yap (2003)
10.3382/ps.2007-00434
An economic and simple purification procedure for the large-scale production of ovotransferrin from egg white.
K. Ko (2008)
10.1196/annals.1331.034
Intracellular Localization of α‐Tocopherol Transfer Protein and α‐Tocopherol
Jinghui Qian (2004)
10.1016/j.fct.2018.10.042
Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions.
R. Santangelo (2019)
10.1128/AAC.21.5.840
Antibacterial activity of matrix-bound ovotransferrin.
P. Valenti (1982)
Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
J. R. Fischer (2002)
10.1021/jf902638e
Novel anticancer activity of the autocleaved ovotransferrin against human colon and breast cancer cells.
H. Ibrahim (2009)
Role of Piperine As A Bioavailability Enhancer
U. Patil (2011)
Dogs and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis
Y. H. Vazquez-Baeza (2016)
10.1089/jmf.2014.7000
The gut microbiome and the brain.
L. Galland (2014)
10.1080/09540109709354950
Inhibition of proliferative responses of mouse spleen lymphocytes by lacto‐ and ovotransferrins
Hajime Otani (1997)
10.1097/00075198-199904000-00006
The gut: the 'motor' of multiple organ dysfunction syndrome?
G. Nieuwenhuijzen (1999)
10.1016/J.TIM.2004.10.008
Does the microbiota regulate immune responses outside the gut?
M. C. Noverr (2004)
10.1007/S00018-005-5372-0
Lactoferrin: an important host defence against microbial and viral attack.
P. Valenti (2005)
10.1038/nmicrobiol.2017.4
Dynamics of the human gut microbiome in Inflammatory Bowel Disease
J. Halfvarson (2017)
10.1007/s002849900339
On the Iron Requirement of Lactobacilli Grown in Chemically Defined Medium
M. Imbert (1998)
10.1038/ni.2608
Control of pathogens and pathobionts by the gut microbiota
N. Kamada (2013)
10.1046/j.1365-2672.2000.01013.x
Iron requirement of Lactobacillus spp. in completely chemically defined growth media
M. Elli (2000)
10.1016/j.biomaterials.2013.11.086
Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Huijun Zhu (2014)
10.3389/fvets.2019.00192
Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory
R. Gupta (2019)
10.1016/j.phrs.2018.04.015
Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease
Naga K R Ghattamaneni (2018)
10.1016/j.ijpharm.2013.01.070
A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.
Zhuoyang Fan (2013)
Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status.
S. P. Yap (2001)
10.1101/gad.284091.116
Metabolites: messengers between the microbiota and the immune system.
M. Levy (2016)
10.1513/AnnalsATS.201306-161MG
Mucosal immunity and the microbiome.
A. Neish (2014)
Effects of “Trikatu” and its individual components and piperine on gastrointestinal tracts: Trikatu: A bioavailable enhancer
A. R. Annamalai (1990)
10.2478/PJVS-2014-0057
Chicken intestinal microbiota function with a special emphasis on the role of probiotic bacteria.
A. A. Cisek (2014)
10.1155/2018/3130607
Composition Analysis and Feature Selection of the Oral Microbiota Associated with Periodontal Disease
Wen-Pei Chen (2018)
Ovotransferrin antimicrobial peptide kills bacteria through a membrane damage mechanism
H. R. Ibrahim (2000)
10.3389/fphar.2018.01482
Integrating Strategies of Herbal Metabolomics, Network Pharmacology, and Experiment Validation to Investigate Frankincense Processing Effects
Z. Ning (2018)
10.1007/BF01868675
Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: Physiological rearrangement of tight junctions
J. Madara (2005)
10.1016/S0014-5793(03)00719-1
Transferrins selectively cause ion efflux through bacterial and artificial membranes
O. Aguilera (2003)
10.1016/0891-5849(91)90174-2
Vitamin E and oxidative stress.
C. Chow (1991)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar